This spontaneous amino acid substitution in the third kinase domain is valuable for the study of semilunar valvulogenesis, mammary gland development, and other epidermal growth factor driven physiology.
Read More +Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Spontaneous | Egfr | epidermal growth factor receptor |
Mice homozygous mice for the waved 2 spontaneous mutation (Egfrwa2) are recognizable at 2 to 3 days by curly whiskers. The first coat is waved but later coats are not; vibrissae usually remain curled and the guard hairs curved. Some homozygotes have eyelids open at birth. Fertile mutant females have smaller than normal mammary glands with reduced milk resulting in impaired lactation. Semilunar valvulogenesis is also abnormal, with a large majority of homozygotes on varied backgrounds displaying enlarged and thickened aortic valves.
In 1933, or shortly thereafter, the waved 2 mutation arose spontaneously in the "abnormal Corpus callosum stock" held by Dr. Clyde Keeler at The Bussey Institute of Harvard Medical School. In 1935 waved 2 (Egfrwa2) was received from Dr. Reed by Dr. G.D. Snell at the Jackson Laboratory. It was crossed to shaker 2 (Myo15sh2) mice of Dr. C.C. Little at The Jackson Laboratory and waved 2 shaker 2 (Egfrwa2 Myo15sh2) mice were crossed to flexed-tail (f) mice received from the Bussey Institute in 1936. All three mutations were maintained in this stock. In 1947 this stock was returned after the fire to Dr. Snell from Dr. Walter Heston. The stock was maintained by non-sibling within-stock matings until 1960 when one outcross was made to C3H/HeJ. The stock was then sibling mated for 13 generations before 3 crosses were made to C57BL/6J, via backcross-intercross, and the stock was then non-sibling within-stock mated and in 1969 two lines were selected, Myo15sh2 and Egfrwa2 and flexed was dropped from these lines. In the Egfrwa2 line a cross was made to B6.Cg-bc, a congenic strain then at N5, and the resulting stock, carrying a and Egfrwa2 but not bc, was sibling mated to maintain Egfrwa2 by forced heterozygosis. It was cryopreserved in 1986 with the common parent at F53. Because recovery of this bankstock proved very difficult this new subline was generated by recovering a few of the original cryopreserved embryos, expanding the colony by sibling breeding for 2 generations then generating cryopreserved embryos from homozygous males outcrossed to (C57BL/6J x C3H/HeJ)F1 females. Sperm was also cryopreserved from homozygous males and cryo-recovery will use (C57BL/6J x C3H/HeJ)F1 oocytes for IVF.
Allele Name | waved 2 |
---|---|
Allele Type | Spontaneous |
Allele Synonym(s) | wa2; wa-2; waved2 |
Gene Symbol and Name | Egfr, epidermal growth factor receptor |
Gene Synonym(s) | |
Strain of Origin | STOCK ac |
Chromosome | 11 |
General Note | Found by Keeler in an ``abnormal corpus callosum'' stock at the Bussey Institution. |
Molecular Note | A T-to-G transversion mutation in the sequences encoding the tyrosine kinase domain results in a substitution of a highly conserved valine with glycine at position 767 (P.V767G) in the third kinase subdomain. |
Some homozygotes may have open eyelids at birth.
When using the STOCK Egfrwa2/2J mouse strain in a publication, please cite the originating article(s) and include JAX stock #025184 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Egfr<wa2> |
Frozen Mouse Embryo | STOCK Egfr<wa2>/2J | $2595.00 |
Frozen Mouse Embryo | STOCK Egfr<wa2>/2J | $2595.00 |
Frozen Mouse Embryo | STOCK Egfr<wa2>/2J | $3373.50 |
Frozen Mouse Embryo | STOCK Egfr<wa2>/2J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.